v3 Template
K

Keros Therapeutics, Inc.

Biotechnology / Healthcare Lexington, Mass., USA ~240 employees
Founded
--
Employees (Est.)
~240
12 leaders known
Total Funding
$411.3M
Funding Rounds
3
Last Funding
2024-01-08

About Keros Therapeutics, Inc.

Keros Therapeutics is a company focused on innovating therapies to shift treatment paradigms for patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. Their mission is inspired by patients and powered by TGF-ß science.

Products & Services

KER-050:A product candidate in the pipeline, likely focused on addressing disorders related to TGF-ß signaling.
KER-065:A product candidate in the pipeline, with specific focus areas including treatment for Duchenne Muscular Dystrophy as indicated by recent FDA Orphan Drug Designation.

Specialties

TGF-ß Science Hematology Neuromuscular Disorders Cellular Growth and Repair

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering
A: 151300000
MR: -
FA: approximately $151.3 million
FAN: 151300000
D: 2024-01-08
FD: 2024-01-08
4 investors
2 RT: Public Offering
T: -
FT: Public Offering
A: 140000000
MR: -
FA: 140.0 million
FAN: 140000000
D: 2024-01-03
FD: 2024-01-03
4 investors
3 RT: Public Offering
T: -
FT: Public Offering
A: 120000000
MR: -
FA: $120.0 million
FAN: 120000000
D: 2024-01-03
FD: 2024-01-03
4 investors
Public Offering Latest
2024-01-08
$151.3M
4 investors (Pro only)
Public Offering 2024-01-03
$140.0M
Public Offering 2024-01-03
$120.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jasbir Seehra

President, Chief Executive Officer and Director

K

Keith Regnante

Chief Financial Officer

L

Lorena Lerner

Chief Scientific Officer

E

Esther Cho

Senior Vice President, General Counsel

J

Jean-Jacques Bienaimé

Chairman

N

Nima Farzan

Member of the Board of Directors

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Keros Therapeutics, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~240 employees (est.)
Locations
Lexington, Mass., USA
Lexington, Mass.
LEXINGTON, Mass.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro